Profile data is unavailable for this security.
About the company
Solventum Corp. is a global healthcare company. Its segments include Medical Surgical, Dental Solutions, Health Information Systems, and Purification and Filtration. Medical Surgical is a provider of solutions including advanced wound care, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. Dental Solutions provides dental and orthodontic products include brackets, aligners, restorative cements, and bonding agents that span the life of the tooth, including products designed for preventative dental care, direct and indirect restoration, and broad orthodontic needs. Health Information Systems offers healthcare systems with software solutions, including computer-assisted physician documentation, direct-to-bill and coding automation, speech recognition, and data visualization platforms. Purification and Filtration is a provider of purification and filtration technologies including filters, purifiers, cartridges, and membranes.
- Revenue in USD (TTM)--
- Net income in USD--
- Incorporated2023
- Employees22.01k
- LocationSolventum CorpC/O 3M Company3M Center, Building 275-6W-02ST. PAUL 55144-1000United StatesUSA
- Phone+1 (651) 733-1110
- Fax+1 (302) 636-5454
- Websitehttps://www.solventum.com/en-us/home/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acadia Healthcare Company Inc | 2.99bn | -11.30m | 6.18bn | 23.50k | -- | 2.13 | 46.24 | 2.07 | -0.1354 | -0.1354 | 32.71 | 31.30 | 0.5667 | -- | 8.17 | 176,030.70 | -0.0653 | 2.32 | -0.0726 | 2.64 | -- | -- | -0.1153 | 5.60 | 1.25 | 5.86 | 0.3843 | -- | 12.20 | 8.99 | -107.93 | -- | 3.34 | -- |
| Ensign Group Inc | 3.85bn | 218.38m | 6.78bn | 35.30k | 31.39 | 4.30 | 23.09 | 1.76 | 3.80 | 3.80 | 66.98 | 27.73 | 0.9431 | -- | 8.00 | 109,141.30 | 5.36 | 6.45 | 6.37 | 7.88 | 21.54 | 22.32 | 5.68 | 6.48 | -- | 40.62 | 0.0858 | 6.56 | 23.27 | 16.28 | -6.80 | 28.62 | 4.40 | 5.02 |
| Encompass Health Corp | 4.96bn | 386.50m | 8.60bn | 22.36k | 22.48 | 4.94 | 11.01 | 1.74 | 3.80 | 3.68 | 48.76 | 17.30 | 0.8276 | -- | 8.74 | 221,721.20 | 8.36 | 6.37 | 10.58 | 7.94 | 95.50 | 95.58 | 10.10 | 9.16 | -- | 5.59 | 0.5298 | 30.78 | 10.41 | 2.34 | 41.31 | 4.49 | 16.60 | -10.42 |
| Chemed Corp | 2.29bn | 283.41m | 8.60bn | 15.09k | 30.60 | 7.24 | 24.92 | 3.75 | 18.58 | 18.58 | 150.33 | 78.46 | 1.45 | 138.48 | 13.85 | 152,017.80 | 17.94 | 19.53 | 21.86 | 24.64 | 35.47 | 34.60 | 12.36 | 12.60 | 1.88 | -- | 0.0114 | 8.15 | 6.06 | 4.90 | 9.17 | 5.80 | 1.46 | 6.10 |
| Solventum Corp | -100.00bn | -100.00bn | 10.63bn | 22.01k | -- | 2.76 | -- | -- | -- | -- | -- | 22.30 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.33 | -- | 0.6832 | -- | 0.8241 | -- | 0.2234 | -- | -- | -- |
| Universal Health Services, Inc. | 14.66bn | 816.29m | 11.86bn | 73.35k | 15.18 | 1.91 | 8.53 | 0.809 | 11.79 | 11.79 | 211.29 | 93.48 | 1.06 | -- | 6.77 | 199,837.00 | 5.96 | 6.44 | 6.98 | 7.63 | -- | -- | 5.61 | 6.55 | 1.28 | 6.16 | 0.4352 | 6.06 | 6.59 | 5.80 | 6.32 | -1.47 | 1.17 | 14.87 |
| Davita Inc | 12.34bn | 815.64m | 11.97bn | 70.00k | 15.50 | 12.93 | 6.48 | 0.9701 | 8.81 | 8.81 | 133.10 | 10.56 | 0.7224 | 66.04 | 5.30 | 176,257.20 | 6.40 | 5.62 | 8.50 | 7.45 | 32.40 | 30.70 | 8.85 | 8.33 | 1.37 | 5.01 | 0.7759 | -- | 4.57 | 1.26 | 26.44 | 2.33 | -10.47 | -- |
| Tenet Healthcare Corp | 20.90bn | 2.62bn | 12.50bn | 78.14k | 4.95 | 3.62 | 2.97 | 0.5981 | 25.87 | 25.87 | 201.91 | 35.35 | 0.7466 | 9.04 | 6.50 | 267,391.00 | 11.97 | 3.61 | 17.38 | 5.09 | 82.64 | 82.97 | 16.03 | 4.95 | 1.37 | 4.49 | 0.6267 | 0.00 | 7.17 | 2.33 | 49.02 | 41.42 | 4.01 | -- |
| Quest Diagnostics Inc | 9.29bn | 842.00m | 15.82bn | 40.00k | 19.17 | 2.46 | 12.01 | 1.70 | 7.43 | 7.43 | 82.00 | 57.95 | 0.6944 | 33.57 | 7.21 | 232,175.00 | 6.51 | 9.28 | 7.61 | 10.81 | 32.95 | 36.64 | 9.37 | 12.97 | 0.8908 | 8.40 | 0.4184 | 25.07 | -6.38 | 4.20 | -9.77 | 3.40 | 1.27 | 7.43 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 01 Apr 2024 | 12.27m | 7.10% |
| SSgA Funds Management, Inc.as of 01 Apr 2024 | 8.96m | 5.19% |
| BlackRock Fund Advisorsas of 01 Apr 2024 | 6.91m | 4.00% |
| BlackRock Investment Management (UK) Ltd.as of 01 Apr 2024 | 1.08m | 0.62% |
| BlackRock Advisors (UK) Ltd.as of 01 Apr 2024 | 1.04m | 0.60% |
| BlackRock Institutional Trust Co. NAas of 05 Apr 2024 | 854.89k | 0.50% |
| BlackRock Financial Management, Inc.as of 01 Apr 2024 | 341.35k | 0.20% |
| BlackRock Japan Co. Ltd.as of 01 Apr 2024 | 272.80k | 0.16% |
| BlackRock Investment Management LLCas of 01 Apr 2024 | 203.00k | 0.12% |
| BlackRock Asset Management Canada Ltd.as of 01 Apr 2024 | 199.75k | 0.12% |
